Credit Suisse’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5
| Closed | -$3 | – | 3255 |
|
|
2022
Q4 | $3 | Hold |
5
| – | – | ﹤0.01% | 3842 |
|
|
2022
Q3 | $0 | Hold |
5
| – | – | ﹤0.01% | 4001 |
|
|
2022
Q2 | $0 | Sell |
5
-325,227
| -100% | – | ﹤0.01% | 3873 |
|
|
2022
Q1 | $233K | Buy |
325,232
+1,463
| +0.5% | +$1.05K | ﹤0.01% | 3317 |
|
|
2021
Q4 | $732K | Buy |
323,769
+92,404
| +40% | +$209K | ﹤0.01% | 2787 |
|
|
2021
Q3 | $666K | Buy |
231,365
+130,774
| +130% | +$376K | ﹤0.01% | 2833 |
|
|
2021
Q2 | $380K | Sell |
100,591
-70,754
| -41% | -$267K | ﹤0.01% | 3171 |
|
|
2021
Q1 | $580K | Sell |
171,345
-457,201
| -73% | -$1.55M | ﹤0.01% | 2870 |
|
|
2020
Q4 | $1.76M | Sell |
628,546
-38,265
| -6% | -$107K | ﹤0.01% | 2212 |
|
|
2020
Q3 | $1.67M | Buy |
666,811
+455,630
| +216% | +$1.14M | ﹤0.01% | 1932 |
|
|
2020
Q2 | $2.87M | Buy |
211,181
+130,562
| +162% | +$1.77M | ﹤0.01% | 1618 |
|
|
2020
Q1 | $611K | Sell |
80,619
-23,800
| -23% | -$180K | ﹤0.01% | 2415 |
|
|
2019
Q4 | $660K | Sell |
104,419
-21,925
| -17% | -$139K | ﹤0.01% | 2769 |
|
|
2019
Q3 | $495K | Buy |
126,344
+22,610
| +22% | +$88.6K | ﹤0.01% | 2804 |
|
|
2019
Q2 | $501K | Buy |
103,734
+2,265
| +2% | +$10.9K | ﹤0.01% | 2783 |
|
|
2019
Q1 | $831K | Buy |
101,469
+6,183
| +6% | +$50.6K | ﹤0.01% | 2491 |
|
|
2018
Q4 | $527K | Buy |
95,286
+64,747
| +212% | +$358K | ﹤0.01% | 2712 |
|
|
2018
Q3 | $270K | Sell |
30,539
-15,387
| -34% | -$136K | ﹤0.01% | 3096 |
|
|
2018
Q2 | $458K | Sell |
45,926
-7,062
| -13% | -$70.4K | ﹤0.01% | 3014 |
|
|
2018
Q1 | $506K | Buy |
52,988
+8,298
| +19% | +$79.2K | ﹤0.01% | 2942 |
|
|
2017
Q4 | $664K | Buy |
44,690
+8,451
| +23% | +$126K | ﹤0.01% | 2794 |
|
|
2017
Q3 | $712K | Buy |
36,239
+12,838
| +55% | +$252K | ﹤0.01% | 2862 |
|
|
2017
Q2 | $336K | Buy |
+23,401
| New | +$336K | ﹤0.01% | 3013 |
|
|
2017
Q1 | – | Sell |
-20,182
| Closed | -$210K | – | 3413 |
|
|
2016
Q4 | $210K | Sell |
20,182
-122
| -0.6% | -$1.27K | ﹤0.01% | 3435 |
|
|
2016
Q3 | $183K | Sell |
20,304
-12,139
| -37% | -$109K | ﹤0.01% | 3493 |
|
|
2016
Q2 | $242K | Buy |
32,443
+18,042
| +125% | +$135K | ﹤0.01% | 3480 |
|
|
2016
Q1 | $130K | Buy |
14,401
+509
| +4% | +$4.6K | ﹤0.01% | 3481 |
|
|
2015
Q4 | $179K | Buy |
13,892
+2,906
| +26% | +$37.4K | ﹤0.01% | 3704 |
|
|
2015
Q3 | $106K | Sell |
10,986
-41,566
| -79% | -$401K | ﹤0.01% | 3871 |
|
|
2015
Q2 | $541K | Buy |
52,552
+24,801
| +89% | +$255K | ﹤0.01% | 3397 |
|
|
2015
Q1 | $309K | Buy |
27,751
+8,056
| +41% | +$89.7K | ﹤0.01% | 3574 |
|
|
2014
Q4 | $229K | Buy |
+19,695
| New | +$229K | ﹤0.01% | 3832 |
|